-
Notifications
You must be signed in to change notification settings - Fork 2
/
dataset-1.txt
24 lines (17 loc) · 874 Bytes
/
dataset-1.txt
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
The CArdiovasCulAr Diabetes & Ethanol (CASCADE) Trial (CASCADE)
Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Safety/Efficacy Study
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Prevention
Official Title: Cardiovascular and Metabolic Effects of Moderate Alcohol Consumption in Type 2 Diabetes
Further study details as provided by Ben-Gurion University of the Negev:
Primary Outcome Measures:
Glycemic control [ Time Frame: 6 months ] [ Designated as safety issue: Yes ]
Secondary Outcome Measures:
CVD status [ Time Frame: 6 months ] [ Designated as safety issue: Yes ]
Estimated Enrollment: 200
Study Start Date: May 2010
Estimated Study Completion Date: May 2012
Estimated Primary Completion Date: May 2012 (Final data collection date for primary outcome measure)